Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations
about
Advantages of an optical nanosensor system for the mechanistic analysis of a novel topoisomerase I targeting drug: a case study.Validation and development of MTH1 inhibitors for treatment of cancer.Chromatin determinants impart camptothecin sensitivity.Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?Assessing chemotherapeutic effectiveness using a paper-based tumor model.
P2860
Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Characterization of DNA topois ...... esistance-associated mutations
@en
type
label
Characterization of DNA topois ...... esistance-associated mutations
@en
prefLabel
Characterization of DNA topois ...... esistance-associated mutations
@en
P2093
P2860
P1476
Characterization of DNA topois ...... esistance-associated mutations
@en
P2093
Birgitta R Knudsen
David Hersi Smith
Hong-Liang Zhang
James H Doroshow
Jan Stenvang
Keli Agama
Maria Unni Rømer
Niels Frank Jensen
Nils Brünner
P2860
P2888
P356
10.1186/S13046-016-0335-X
P50
P577
2016-03-31T00:00:00Z
P5875
P6179
1008942105